HBI Deals+Insights / Healthcare Reform
Last month we reported that there is a growth opportunity for bigger and more efficient for-profits in the largely unconsolidated Dutch labs market, as Covid testing winds down and financial pressures return to the sector. But a consultant who has previously run a Dutch hospital lab tells us a major barrier remains: a stubborn reluctance within hospitals to outsource.